Patent details

EP2374796 Title: 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes

Basic Information

Publication number:
EP2374796
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100102979
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorderes
French Title of Invention:
8-Chloro-1-méthyl-2,3,4,5-tétrahydro-1H-3-benzazepine, ses sels, solvates ou hydrates et son utilisation dans le traitement des troubles du SNC
German Title of Invention:
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin, seine Salze, Solvate oder Hydrate und seine Verwendung zur Behandlung von ZNS-Erkrankungen
SPC Number:

Dates

Filing date:
11/04/2003
Grant date:
28/02/2018
EP Publication Date:
12/10/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2018
EP B1 Publication Date:
28/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/04/2018
Expiration date:
11/04/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/02/2018
 
 

Name:
Arena Pharmaceuticals, Inc.
Address:
6154 Nancy Ridge Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:
Smith, Jeffrey
Address:
United States (US)

2

Name:
Smith, Brian
Address:
United States (US)

Priority

1

Priority Number:
372058 P
Priority Date:
12/04/2002
Priority Country:
United States (US)

2

Priority Number:
405495 P
Priority Date:
23/08/2002
Priority Country:
United States (US)

3

Priority Number:
434607 P
Priority Date:
18/12/2002
Priority Country:
United States (US)

4

Priority Number:
410991
Priority Date:
10/04/2003
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/20; A61K 31/55; A61P 3/00; A61P 9/00; A61P 25/00; C07D 223/16; C07D 403/04; C07D 409/04; C07D 491/04;

Publication

European Patent Bulletin

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1